Company: DAWN
Filing Date: 2025-08-05
Form Type: 8-K
Source: 0000950170-25-102969
Chunk: 0

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-08-05
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On August 5, 2025, Day One Biopharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. A copy of the Company’s presentation with respect to its financial results for the quarter ended June 30, 2025 is attached as Exhibit 99.2 to this report.